Company: AEMD
Filing Date: 2025-06-26
Form Type: 10-K
Source: 0001683168-25-004780
Chunk: 1980

Company: AETHLON MEDICAL INC
Filing Date: 2025-06-26
Form: 10-K
Item: Item 16
Chunk 1980
---
as a non-cash inducement expense in other expense and reflected as an increase to additional paid-in capital.

ISSUANCES OF COMMON STOCK AND WARRANTS

Equity Transactions in the Fiscal Year Ended March 31, 2025.

March 2025 Warrant-Based
Financing

On March 16, 2025, the
Company entered into an inducement offer to exercise existing Class A and Class B Warrants
(the “Agreement”) with a certain accredited and institutional holder (the “Holder”) of the Company’s outstanding
Class A and Class B Warrants issued on May 17, 2024 (the “Existing Warrants”). Pursuant
to the Agreement, the Holder, upon exercise, will receive a new unregistered Common Stock Purchase Warrant (“New Warrant”)
pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended (“Securities Act”), to purchase up to a number of shares
equal to 200% of the number of Warrant Shares issued pursuant to the exercise of Existing Warrants pursuant to this Agreement (the “New
Warrant Shares”), which New Warrant shall have an exercise price per share equal to $0.3736, subject to adjustment as provided
in the New Warrant, will be exercisable at any time on or after six (6) months from the date of issuance and have a term of exercise
of five and one-half (5.5) years from the date of issuance and (ii) a reduction of the exercise price of the Existing Warrants to $0.3736
per share, representing the closing price on March 14, 2025, but only with respect to a cash exercise under the Existing Warrants
(as reduced from the current respective exercise price per share as set forth in the Existing Warrants).

     F-16 

The closing took place
on March 17, 2025. Gross proceeds to the Company from the exercise of the Existing Warrants was $2,316,320, prior to deducting
closing costs and placement agent fees as further described below. The Company intends to use the net proceeds from the offering for working
capital and general corporate purposes.

As a result of the Holder
exercising the Existing Warrants, the Company issued an aggregate of 6,200,000 shares of its common stock. The shares underlying the Existing
Warrants have all been registered on Form S-1